Procalcitonin for reduced antibiotic exposure in the critical care setting: A systematic review and an economic evaluation*
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Procalcitonin may be associated with reduced antibiotic usage compared to usual care. However, individual randomized controlled trials testing this hypothesis were too small to rule out harm, and the full cost-benefit of this strategy has not been evaluated. The purpose of this analysis was to evaluate the effect of a procalcitonin-guided antibiotic strategy on clinical and economic outcomes. INTERVENTIONS: The use of procalcitonin-guided antibiotic therapy. METHODS AND MAIN RESULTS: We searched computerized databases, reference lists of pertinent articles, and personal files. We included randomized controlled trials conducted in the intensive care unit that compared a procalcitonin-guided strategy to usual care and reported on antibiotic utilization and clinically important outcomes. Results were qualitatively and quantitatively summarized. On the basis of no effect in hospital mortality or hospital length of stay, a cost or cost-minimization analysis was conducted using the costs of procalcitonin testing and antibiotic acquisition and administration. Costs were determined from the literature and are reported in 2009 Canadian dollars. Five articles met the inclusion criteria. Procalcitonin-guided strategies were associated with a significant reduction in antibiotic use (weighted mean difference -2.14 days, 95% confidence interval -2.51 to -1.78, p < .00001). No effect was seen of a procalcitonin-guided strategy on hospital mortality (risk ratio 1.06, 95% confidence interval 0.86-1.30, p = .59; risk difference 0.01, 95% confidence interval -0.04 to +0.07, p = .61) and intensive care unit and hospital lengths of stay. The cost model revealed that, for the base case scenario (daily price of procalcitonin Can$49.42, 6 days of procalcitonin measurement, and 2-day difference in antibiotic treatment between procalcitonin-guided therapy and usual care), the point at which the cost of testing equals the cost of antibiotics saved is when daily antibiotics cost Can$148.26 (ranging between Can$59.30 and Can$296.52 on the basis of different assumptions in sensitivity analyses). CONCLUSIONS: Procalcitonin-guided antibiotic therapy is associated with a reduction in antibiotic usage that, under certain assumptions, may reduce overall costs of care. However, the overall estimate cannot rule out a 7% increase in hospital mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Use of Procalcitonin to Shorten Antibiotic Treatment Duration in Septic Patients
Nobre, V., Harbarth, S., Graf, J.-D., Rohner, P., & Pugin, J. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200708-1238oc · Cited by 605 · cited 5×
“Prior antibiotics, 0% (excluded if on prior) Surgical, 100% 3 Schroeder et al, 2009 (29) Abdominal surgery with severe sepsis (27) Positive culture, 65% Concealed, yes; ITT, yes PCT done daily; antibiotic therapy stopped if PCT 1 ng/L or if PCT 1 ng/mL but had dropped at least 25% to 35% less than the baseline value A…”
BackgroundResultInfluentialHochreiter, M., Köhler, T., Schweiger, A. M., Keck, F. S., Bein, B., von Spiegel, T., & Schroeder, S. (2009) · Critical Care · doi:10.1186/cc7903 · Cited by 315 · cited 5×
“With the exception of the two RCTs from the same group (28, 29), all the studies used different arbitrarily derived decision rules to guide antibiotic discontinuation.”
BackgroundResultInfluentialSchroeder, S., Hochreiter, M., Koehler, T., Schweiger, A.-M., Bein, B., Keck, F. S., & von Spiegel, T. (2009) · Langenbeck's Archives of Surgery · doi:10.1007/s00423-008-0432-1 · Cited by 238 · cited 7×
“With the exception of the two RCTs from the same group (28, 29), all the studies used different arbitrarily derived decision rules to guide antibiotic discontinuation.”
BackgroundResultInfluential
Cited by
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Alhazzani, W., Møller, M. H., Arabi, Y. M., Loeb, M., Gong, M. N., Fan, E., Oczkowski, S., Levy, M. M., Derde, L., Dzierba, A., et al. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004363 · Cited by 1,565
Torres, A., Niederman, M. S., Chastre, J., Ewig, S., Fernandez-Vandellos, P., Hanberger, H., Kollef, M., Li Bassi, G., Luna, C. M., Martin-Loeches, I., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00582-2017 · Cited by 1,387
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
Schuetz, P., Wirz, Y., Sager, R., Christ-Crain, M., Stolz, D., Tamm, M., Bouadma, L., Luyt, C. E., Wolff, M., Chastre, J., et al. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007498.pub3 · Cited by 649
Permissive underfeeding or standard enteral feeding in critically ill adults
Arabi, Y. M., Aldawood, A. S., Haddad, S. H., Al-Dorzi, H. M., Tamim, H. M., Jones, G., Mehta, S., McIntyre, L., Solaiman, O., Sakkijha, M. H., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1502826 · Cited by 614
The Neutrophil-Lymphocyte Count Ratio in Patients with Community-Acquired Pneumonia
de Jager, C. P. C., Wever, P. C., Gemen, E. F. A., Kusters, R., van Gageldonk-Lafeber, A. B., van der Poll, T., & Laheij, R. J. F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046561 · Cited by 328
Permissive underfeeding or standard enteral feeding in critically ill adults
Aldridge, K. (2015) · Journal of the Intensive Care Society · doi:10.1177/1751143715607732 · Cited by 320
Schuetz, P., Birkhahn, R., Sherwin, R., Jones, A. E., Singer, A., Kline, J. A., Runyon, M. S., Self, W. H., Courtney, D. M., Nowak, R. M., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002321 · Cited by 296
Schuetz, P., Briel, M., Christ-Crain, M., Stolz, D., Bouadma, L., Wolff, M., Luyt, C.-E., Chastre, J., Tubach, F., Kristoffersen, K. B., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis464 · Cited by 280
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
Schuetz, P., Müller, B., Christ-Crain, M., Stolz, D., Tamm, M., Bouadma, L., Luyt, C. E., Wolff, M., Chastre, J., Tubach, F., et al. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007498.pub2 · Cited by 264
Ulla, M., Pizzolato, E., Lucchiari, M., Loiacono, M., Soardo, F., Forno, D., Morello, F., Lupia, E., Moiraghi, C., Mengozzi, G., et al. (2013) · Critical Care · doi:10.1186/cc12847 · Cited by 260
Prkno, A., Wacker, C., Brunkhorst, F. M., & Schlattmann, P. (2013) · Critical Care · doi:10.1186/cc13157 · Cited by 260
The Clinical Challenge of Sepsis Identification and Monitoring
Vincent, J.-L. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002022 · Cited by 259
“PCT levels have been used to guide antibiotic therapy in several clinical trials in different groups of infected patients with promising results on antibiotic use [44,45].”
MethodOliveira, C. F., Botoni, F. A., Oliveira, C. R. A., Silva, C. B., Pereira, H. A., Serufo, J. C., & Nobre, V. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31828e969f · Cited by 213
Wei, X., Day, A. G., Ouellette-Kuntz, H., & Heyland, D. K. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000001000 · Cited by 187
Self-citationWinning the war against ICU-acquired weakness: new innovations in nutrition and exercise physiology
Wischmeyer, P. E., & San-Millan, I. (2015) · Critical Care · doi:10.1186/cc14724 · Cited by 153
The Effects of Critical Illness on Intestinal Glucose Sensing, Transporters, and Absorption*
Deane, A. M., Rayner, C. K., Keeshan, A., Cvijanovic, N., Marino, Z., Nguyen, N. Q., Chia, B., Summers, M. J., Sim, J. A., van Beek, T., et al. (2014) · Critical Care Medicine · doi:10.1097/ccm.0b013e318298a8af · Cited by 84
Collins, C. D., Brockhaus, K., Sim, T., Suneja, A., & Malani, A. N. (2019) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxz129 · Cited by 25
Metadata
- Authors
- Heyland, D. K., Johnson, A. P., Reynolds, S. C., & Muscedere, J.
- Venue
- Critical Care Medicine
- Published
- 2011-07
- Volume
- 39
- Issue
- 7
- Pages
- 1792-1799
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W2030737851
- Cited by
- 213
- References
- 3
- FWCI
- 3.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.